Role of Drugs in COVID 19 Patient: A Review
Journal of Pharmaceutical Research International · pp. 99–105 · Published 9 Jul 2021
10.9734/jpri/2021/v33i36A31931Abstract
Background: No specific drug treatment is available for the COVID-19. Various drugs are being used and repurposed as COVID-19 treatment. Summary: COVID-19 has no defined treatment course because it has no precedent. Various drugs are tried and tested to be used upon patients to treat particular symptom. Hydroxycholoroquine, lopinavir, ritonavir and so on are the famous drugs being repurposed as COVID-19 treatment drugs. Prophylactics are not widely listed but supplements and drugs which contain anti-inflammatory properties and anti-oxidants should be inculcated in the diet so that innate immune response can fight off the external pathogenic invasion all by itself. Conclusion: Drugs listed for repurposing method must be tried and tested before administered it to a severely ill patients or to a large chunk of population. Proper study needs to be done before administered and starting full-fledged usage of any existing drug not meant for the treatment of COVID-19.
Cited by 3
Priyanka, Komal Parmar, Sharma Vedika Vijaypal · Drug Repurposing for Antivirals · 2025
Mukhtar H. Ahmed, Arez Hassan, Judit Molnár · Revista Brasileira de Farmacognosia · 2021
Anderson Lopes, Francisca P. Araújo, Dihego Damasceno · Sustainability · 2023
Article metrics
Real usage data collected on this platform.
9
Page views
0
PDF downloads
9
Outbound clicks
3
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.